← Back to Search

N/A

Peer Support for Lupus (PALS Trial)

N/A
Waitlist Available
Led By Edith Williams, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female sex
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months post-intervention
Awards & highlights

PALS Trial Summary

This trial is investigating whether a peer mentoring intervention can help African American women with lupus manage their condition.

Who is the study for?
This trial is for African American women over 18 with lupus (SLE), diagnosed by a doctor, who've had the disease for more than 2 years. They should be willing to support others with SLE and can attend training sessions. Women who were mentees in the pilot study can't join as mentees again but may qualify as mentors.Check my eligibility
What is being tested?
The PALS study tests if peer mentoring helps manage lupus better. Participants are randomly chosen to either get phone calls from trained peers every two weeks or join a social support group, both lasting six months, with follow-ups until one year.See study design
What are the potential side effects?
Since this trial involves peer mentoring and social support rather than medication, there aren't typical drug side effects. However, participants might experience emotional distress or discomfort sharing personal health information.

PALS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with lupus by a doctor.
Select...
My condition has been diagnosed for over 2 years.

PALS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Self-management
Satisfaction in Quality of Life as assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Measurement System
Satisfaction in Quality of Life as assessed by the LUP-QOL (Lupus Quality of Life Questionnaire
Secondary outcome measures
Satisfaction with care: validated general scale
Treatment Credibility

PALS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer MentoringExperimental Treatment1 Intervention
The program will consist of 12 sessions of peer mentoring that will include one standard educational session by telephone or video for approximately 60 minutes every 2 weeks. Additional interaction will be discouraged, but mentees and mentors will be asked to report any additional social interaction should it occur. The bi-weekly educational session will be generally structured in three parts: introduction, structured education, and problem solving. 60-minute calls are necessary for the delivery of educational content and mentors and mentees to be able to discuss their own experiences and potential solutions.
Group II: Social Support GroupActive Control1 Intervention
Mentees randomized to the social support control group will be enrolled in a lupus support group designed specifically for this project.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer Mentoring
2017
N/A
~1070

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
575 Previous Clinical Trials
10,355,229 Total Patients Enrolled
1 Trials studying Lupus
672 Patients Enrolled for Lupus
Medical University of South CarolinaLead Sponsor
929 Previous Clinical Trials
7,393,473 Total Patients Enrolled
1 Trials studying Lupus
120 Patients Enrolled for Lupus
Edith Williams, PhDPrincipal InvestigatorMedical University of South Carolina

Media Library

Peer Mentoring (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT03734055 — N/A
Lupus Research Study Groups: Peer Mentoring, Social Support Group
Lupus Clinical Trial 2023: Peer Mentoring Highlights & Side Effects. Trial Name: NCT03734055 — N/A
Peer Mentoring (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03734055 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this experiment still open?

"Clinicaltrials.gov reveals that this trial, which was first entered into the database on November 30th 2018 and updated most recently June 30th 2022, is not currently recruiting participants. Although it has halted enrollment, there are 443 other clinical trials actively searching for volunteers right now."

Answered by AI
~15 spots leftby Jun 2024